For adults aged 65 years and older with Alzheimer’s disease, the emergency department visit rate was 36.1 visits per 1,000 adults in 2020 to 2022,…
An new study led by the Center for Addiction and Mental Health (CAMH), and with partnership across several Toronto Dementia Research Alliance (TDRA) sites—Baycrest, Sunnybrook…
Physical activity of any intensity after a diagnosis of dementia is associated with around a 30% lower risk of death, finds research published online in…
The UK’s drugs regulator—the MHRA—has approved the Alzheimer’s drug donanemab, but it won’t be available on the NHS.
Halloween is meant to be a spooky season, but it can be downright terrifying to someone suffering from Alzheimer’s disease or dementia.
The treatment of dementia disorders such as Alzheimer’s is still one of the greatest challenges facing modern medicine. In the course of neurodegenerative diseases, certain…
A new study by researchers at Florida State University’s Gut Biome Lab has revealed a potential link between an infection caused by gut bacteria and…
A collaborative research group has uncovered a new mechanism in the growth of amyloid β (Aβ) fibrils, which are closely associated with Alzheimer’s disease. Using…
Researchers at the Case Western Reserve School of Medicine have found that when compared to seven other anti-diabetic drugs, semaglutide, a popular diabetes and weight-loss…
Britain’s drug regulator approved the Alzheimer’s drug Kisunla on Wednesday, but the government won’t be paying for it after an independent watchdog agency said the…